Literature DB >> 18022078

Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?

Christopher M Burton1, Martin Iversen, Jann Mortensen, Jørn Carlsen, Claus B Andersen, Nils Milman, Thomas Scheike.   

Abstract

BACKGROUND: Because bronchiolitis obliterans syndrome (BOS) is defined and graded according to the decline in forced expiratory volume in 1 second (FEV(1)) relative to a maximal baseline value obtained post-transplantation, the criteria discriminates against recipients with lower maximal baseline values (i.e., constitutes a statistical bias). This study describes the effect of transplant procedure on the development of BOS, adjusting for the absolute value of post-transplant baseline FEV(1).
METHODS: All patients receiving a cadaveric lung transplant from 1992 to 2004 were included in the study (n = 389). Exclusion criteria were patients surviving <3 months (n = 39) and missing spirometry measurements (n = 4).
RESULTS: Baseline FEV(1) was strongly associated with the freedom from BOS Grade 1, and longer-duration BOS-free survival in univariate and multivariate survival analyses. After adjusting for baseline FEV(1), and recipient-donor gender, bilateral lung transplantation (BLT) was associated with an increase in the cause-specific risk of BOS Grade 1 (hazard ratio [HR] 2.0, confidence interval [CI] 1.2 to 3.1, p = 0.004), and an increase in the cause-specific risk of death/re-transplantation or BOS Grade 1 as a combined end-point (HR 2.3, CI 1.5 to 3.4, p < 0.0001) compared with single-lung transplantation (SLT). In the competing risk regression model adjusting for recipient-donor gender and transplant procedure, only baseline FEV(1) remained independently associated with the cumulative incidence of BOS Grade 1 (p < 0.05); however, BLT recipients were more likely to have death/re-transplantation unrelated to BOS than SLT recipients.
CONCLUSIONS: The absolute value of baseline lung function appears to be an important confounder in the analyses of BOS, and should be considered in future risk factor analyses.

Entities:  

Mesh:

Year:  2007        PMID: 18022078     DOI: 10.1016/j.healun.2007.07.041

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

1.  25-year follow-up after lung transplantation at Lund University Hospital in Sweden: superior results obtained for patients with cystic fibrosis.

Authors:  Mohammed Fakhro; Richard Ingemansson; Ingrid Skog; Lars Algotsson; Lennart Hansson; Bansi Koul; Ronny Gustafsson; Per Wierup; Sandra Lindstedt
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-04-06

2.  Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.

Authors:  S S Weigt; C A Finlen Copeland; A Derhovanessian; M Y Shino; W A Davis; L D Snyder; A L Gregson; R Saggar; J P Lynch; D J Ross; A Ardehali; R M Elashoff; S M Palmer; J A Belperio
Journal:  Am J Transplant       Date:  2013-02-07       Impact factor: 8.086

Review 3.  Improving survival outcomes in lung transplant recipients through early detection of bronchiolitis obliterans: Daily home spirometry versus standard pulmonary function testing.

Authors:  Kevin S Robson; Andrew J West
Journal:  Can J Respir Ther       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.